LC
DGX icon

Luminist Capital’s Quest Diagnostics DGX Stock Holding History

Luminist Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.1K Buy
+189
New +$37.1K 0.05% 108
2026
Q1 		– Sell
-189
Closed -$32.8K – 138
2025
Q4 		$32.8K Hold
189
– – 0.04% 91
2025
Q3 		$34.4K Hold
189
– – 0.03% 130
2025
Q2 		$33.9K Hold
189
– – 0.03% 107
2025
Q1 		$32K Hold
189
– – 0.03% 87
2024
Q4 		$28.5K Buy
+189
New +$29.4K 0.05% 85

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Luminist Capital's DGX Position: Q2 2026 in Review

Luminist Capital opened a new position in Quest Diagnostics (DGX) in Q2 2026: 189 shares worth $40.1K. The stake represents 0.05% of the portfolio and ranks #108 among its holdings. This is a return to the name: Luminist Capital previously reported a position in DGX as recently as Q4 2025.

Luminist Capital first reported a position in DGX in Q4 2024 and has held it in 6 quarters since. 1,107 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Luminist Capital held 189 shares of Quest Diagnostics worth $40.1K as of Q2 2026.
  • Quest Diagnostics was a new Luminist Capital position in Q2 2026.
  • Quest Diagnostics made up 0.05% of Luminist Capital's portfolio in Q2 2026, its #108 holding.
  • Luminist Capital first reported a position in Quest Diagnostics in Q4 2024 and has held it in 6 quarters since.
  • 1,107 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Luminist Capital's 13F filing for Q2 2026, filed 7 Aug 2026.